Timber Hill’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-10,226
Closed -$820K 2531
2016
Q4
$820K Buy
+10,226
New +$812K ﹤0.01% 1391
2016
Q2
Sell
-14,116
Closed -$1.01M 2430
2016
Q1
$776K Buy
14,116
+5,349
+61% +$291K ﹤0.01% 1379
2015
Q4
$542K Sell
8,767
-8,559
-49% -$540K ﹤0.01% 1655
2015
Q3
$1.09M Buy
17,326
+14,547
+523% +$1.04M ﹤0.01% 1357
2015
Q2
$203K Sell
2,779
-8,823
-76% -$637K ﹤0.01% 2344
2015
Q1
$759K Buy
11,602
+4,824
+71% +$321K ﹤0.01% 1577
2014
Q4
$441K Sell
6,778
-6,244
-48% -$402K ﹤0.01% 1943
2014
Q3
$783K Buy
13,022
+7,308
+128% +$477K ﹤0.01% 1732
2014
Q2
$396K Sell
5,714
-19,100
-77% -$1.24M ﹤0.01% 2245
2014
Q1
$1.62M Sell
24,814
-3,023
-11% -$197K 0.01% 1291
2013
Q4
$1.73M Sell
27,837
-65,783
-70% -$3.81M 0.01% 1475
2013
Q3
$5.02M Buy
+93,620
New +$4.82M 0.02% 845

Other funds holding STJ

Timber Hill's STJ Position: Q1 2017 in Review

Timber Hill sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 10,226 shares — an estimated $820K sold.

Timber Hill first reported a position in STJ in Q3 2013 and held it in 12 quarters. The position peaked at $5.02M in Q3 2013. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Timber Hill reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Timber Hill sold 10,226 St Jude Medical shares in Q1 2017, an estimated $820K.
  • Timber Hill first reported a position in St Jude Medical in Q3 2013 and held it in 12 quarters.
  • Timber Hill's St Jude Medical position peaked at $5.02M in Q3 2013.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Timber Hill's 13F filing for Q1 2017, filed 10 May 2017.